HHSF223201610017B-75F40119F19002
BPA Call
Overview
Government Description
FDA SAFETY AND INNOVATION ACT (FDASIA) SUPPORT SERVICES NEW DRUG MODERNIZATION IMPLEMENTATION SUPPORT
Alternate Description
FDA CDER New Drug Modernization Implementation Support
Awardee
Awarding / Funding Agency
Place of Performance
Silver Spring, MD 20993 United States
Pricing
Time And Materials
Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/18/22 to 12/26/22.
Predecessor This appears to be a continuation of a prior contract HHSF223201510012B-75F40118F18002.
Predecessor This appears to be a continuation of a prior contract HHSF223201510012B-75F40118F18002.
Booz Allen Hamilton was awarded
BPA Call 75F40119F19002 (75F401-19-F-19002)
for Fda Safety And Innovation Act (FDASIA) Support Services New Drug Modernization Implementation Support
worth up to $14,506,774
by the FDA Office of Acquisition and Grant Services
in September 2019.
The contract
has a duration of 3 years 3 months and
was awarded
through solicitation Professional Service Schedule
full & open
with
NAICS 541611 and
PSC R405
via subject to multiple award fair opportunity acquisition procedures with 2 bids received.
This contract was awarded through vehicle FDA Safety And Innovation Act Support Services (FDASIA) Drug Destruction.
Status
(Closed)
Last Modified 6/21/24
Period of Performance
9/10/19
Start Date
12/26/22
Current End Date
12/26/22
Potential End Date
Obligations
$14.5M
Total Obligated
$14.5M
Current Award
$14.5M
Potential Award
Award Hierarchy
Federal Supply Schedule
Blanket Purchase Agreement
BPA Call
HHSF223201610017B-75F40119F19002
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for HHSF223201610017B-75F40119F19002
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2020 | $2,746,719 | 21,244.3 | 10.2 | $129.29 |
| 2021 | $2,981,485 | 29,359.5 | 14.1 | $101.55 |
| 2022 | $5,575,708 | 37,358.9 | 17.9 | $149.25 |
| 2023 | $2,412,498 | 14,758.5 | 7.1 | $163.46 |
Subcontract Awards
Disclosed subcontracts for HHSF223201610017B-75F40119F19002
Opportunity Lifecycle
Procurement history for HHSF223201610017B-75F40119F19002
Transaction History
Modifications to HHSF223201610017B-75F40119F19002
People
Suggested agency contacts for HHSF223201610017B-75F40119F19002
Competition
Number of Bidders
2
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
None
Other Categorizations
Subcontracting Plan
Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
JCBMLGPE6Z71
Awardee CAGE
17038
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsjuliettewilliams
Last Modified By
hhsjames_jenrette
Approved By
hhsjames_jenrette
Legislative
Legislative Mandates
Labor Standards
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Other services from non-Federal sources (25.2) | $6,898,756 | 80% |
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Other goods and services from Federal sources (25.3) | $1,699,911 | 20% |
Modified: 6/21/24